WASHINGTON -- The Obama administration has alarmed global health experts by opposing a new international fund that would fight disease in the developi...

WASHINGTON -- The deals that the White House cut with major industries during the health care debate are threatening to come back to haunt the adminis...

This morning the White House released a new health care proposal that may be used as a blueprint for a compromise between House and Senate versions of...

By Lindsay Beyerstein, Media Consortium Blogger You will be shocked, shocked to hear that a Blue Dog Democrat who made a career out of undermining his...

Within a few months of being sworn in, the President and his aides were sitting down with leaders from the pharma industry to hash out a deal that they thought would make health care reform possible.

WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...

Now that Scott Brown is on his way to the U.S. Senate, the press is wondering if health care reform is alive, dead, or shambling ever-forward like som...

Sen. Bill Nelson, a Florida Democrat, said on Sunday that if leadership doesn't work with him on his amendment that would break the White House deal w...

While the Senate wonders just what it is that Joe Lieberman wants in a health care bill, the standoff over pharmaceutical provisions continues. Sen. B...

Four years ago, a group of lawmakers and aides crafted Medicare Part D, the prescription drug program for seniors that has produced billions of dollar...

This past weekend, the New York Times's Katharine Seelye took stock of the advertising battle that's been raging over health care reform, to the tune ...

The American people did not vote for "bipartisan" solutions that split the difference between the failed ideology of the last eight years and the change the president and the super-majorities they elected in both houses of Congress promised.

Reformers were naïve if they thought the world had changed simply because there were new tenants in the majority offices on the Hill or in the White House.

I'm a strong supporter of universal health insurance, and a fan of the Obama administration. But I'm appalled by the deal the White House has made with the pharmaceutical industry's lobbying arm to buy their support.

In yet another in a series of evolving statements and backtracks, an official with the country's major pharmaceutical lobby said on Monday that it nev...

The White House may be willing to cave on drug price negotiations and having a public option. Giving us health care reform without those key ingredients is like serving a PBJ sandwich without the peanut butter or the jelly.

Bringing lobbyists from Big Pharma into the health care negotiations is anathema to the process and makes them feel like they deserve a place at that table.

The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.

In today's Los Angeles Times Tom Hamburger reports on the extent to which former Louisiana Congressman Billy Tauzin has managed to integrate himself, ...

The Eshoo/Barton amendment, which has the support of many newly pro-PhRMA democrats, will extend the period of monopolies for biologic medicines.